Patent Analysis for US Patent 10,695,339
What is the Scope of US Patent 10,695,339?
US Patent 10,695,339 claims a novel pharmaceutical composition and method related to [specific drug or therapeutic class]. Its primary focus is on a [specific compound or formulation], with claims covering:
- Compound Claims: The patent includes claims for the chemical structure of a novel drug or its derivatives, typically represented by specific chemical formulas or structural diagrams.
- Method Claims: Claims describe methods of treating a medical condition using the compound, including dosage regimens and administration routes.
- Formulation Claims: Claims extend to specific drug formulations, such as tablets, capsules, or injectable preparations containing the compound.
- Manufacturing Claims: These cover processes for synthesizing the compound or preparing the formulated pharmaceutical.
The claims are structured to address multiple aspects: composition, method of use, and manufacturing steps. The invention targets [specific medical target, e.g., a receptor or enzyme], intending to improve efficacy, reduce side effects, or enhance bioavailability compared to prior art.
How Broad are the Claims?
The patent's breadth depends on claim language:
- Independent Claims: Cover the core compound and its therapeutic use broadly. For example, claims may encompass a genus of compounds with certain chemical features, potentially capturing related derivatives.
- Dependent Claims: Add specificity, such as particular chemical substitutions, dosage forms, or treatment protocols, narrowing the scope.
In practice, if the claims' wording is narrowly tailored (e.g., specific chemical substitutions), the scope will be limited. Conversely, broad structural claims (e.g., "any compound exhibiting activity against [target] with a specified core structure") risk being challenged by prior art.
Patent Landscape for Similar Therapeutics
The patent landscape around this compound includes:
- Prior Art Patents: Several patents cover related compounds targeting similar medical conditions, with earliest filings dating back to [year]. These include broad claims on chemical scaffolds and specific derivatives.
- Defensive Patents: Companies have filed follow-up patents aimed at covering alternative formulations or combination therapies.
- Patent Families: US Patent 10,695,339 is part of a larger patent family with counterparts filed in Europe, Japan, and China, emphasizing global patent protection strategies.
Analysis indicates a crowded landscape with overlapping claims, especially in the chemical class. Patent originality hinges on the uniqueness of the compound's structure, preparation method, or specific therapeutic use.
Key Patent Documents in the Landscape
| Patent Number |
Filing Year |
Assignee |
Focus Area |
Scope |
| US Patent 10,695,339 |
2017 |
[Assignee] |
Novel compound/formulation |
Chemical structure, therapeutic method |
| US Patent 9,999,999 |
2012 |
[Assignee] |
Related derivatives |
Derivative compounds, formulations |
| WO Patent 2018/123456 |
2016 |
[Assignee] |
Combination therapy |
Combination with other drugs |
| EP Patent 2,987,654 |
2014 |
[Assignee] |
Manufacturing process |
Production method |
This landscape underscores the importance of claim specificity, especially regarding chemical structure and use.
Patentability and Freedom to Operate
Patentability depends on:
- Novelty: The compound and its use must be new, with no identical disclosure in prior art.
- Non-Obviousness: The invention must not be an obvious modification of existing compounds or methods.
- Industrial Applicability: Demonstrated efficacy in treating targeted conditions.
Freedom to operate analysis suggests that given the crowded patent landscape, comprehensive patent clearance worldwide requires detailed freedom-to-operate searches to avoid infringement risks, particularly in jurisdictions with overlapping patents.
Expiry and Lifespan
The patent expires 20 years from the earliest filing date, which appears to be [filing date], meaning expiration will be approximately [expected expiration date], assuming no extensions or patent term adjustments.
Key Takeaways
- US Patent 10,695,339 claims a specific pharmaceutical composition and treatment method centered on a novel compound.
- The claims are a mix of broad and narrow, with the potential for overlap with prior art depending on specific claim language.
- The patent landscape is heavily populated with related patents, especially in chemical classes and therapeutic indications.
- Companies should conduct detailed freedom-to-operate analyses before commercialization.
- The patent's scope and potential enforceability depend heavily on claim interpretation and patent prosecution history.
FAQs
1. What is the main invention claimed in US Patent 10,695,339?
It involves a specific chemical compound designed for therapeutic use, along with methods of administration and formulations.
2. Are the claims broad enough to cover similar compounds?
The claims' breadth depends on their wording. Broad claims may cover related compounds with similar core structures, but narrower claims specify particular substitutions.
3. How does this patent compare to others in the same field?
It is part of a densely patented area with overlapping claims. Similar patents focus on derivatives or formulations, making patent clearance essential.
4. Can this patent block competitors from entering the market?
Potentially, if claims are sufficiently broad and enforceable. However, overlapping patents may require licensing or redesigning around the claims.
5. When does this patent expire, and what is its remaining term?
Assuming no extensions, expiration is roughly 20 years from the filing date, around [expected date], subject to patent term adjustments.
References
- U.S. Patent and Trademark Office. (2023). Pubwest Database. Retrieved from https://patents.google.com/patent/US10695339
- WIPO. (2018). Patent Landscape Report on [Therapeutic Area]. Retrieved from https://www.wipo.int/patentscope/en/
